BioPharma Strategy Cases

This casebook is uniquely intended to address the niche created by the intersection of business strategy with biotechnology and pharmaceuticals. In addition, it highlights some recent trends (both opportunities and threats) in the field if life sciences. As authors of business strategy cases may attest, the difficulty in obtaining current information may cause lags in subject area coverage. Indeed, some of the cases in this book also underscore the surprisingly vast spaces in the life sciences sector, in which opportunities may abound. This casebook also features several advancements in adjacent industries that have and will continue to have implications for biopharma firm strategies. In particular, advancements in the design of experiments and statistics, chemistry, artificial intelligence, quantum computing, finance, and microfluidics, to name but a few, are featured. This casebook is also designed to showcase novel applications of or insights into strategic management theory. Issues in ecosystem leadership, opportunity costs and bioethics, dominant design/industry life cycle, intangible sources of sustained advantage, leveraging public projects for private gain, corporate identity, and postmodern perspectives on the resource-based view are addressed. Finally, this case book is also written in a format which is compatible with most standard textbook treatments of strategic management.